PMDA drug package insert
ピコスルファートナトリウム錠2.5mg「FSK」
PMDA Prescription drug · 株式会社伏見製薬所 · package insert Dec 1, 2023
Key facts
| Brand names | ピコスルファートナトリウム錠2.5mg「FSK」 |
|---|---|
| Nonproprietary names | ピコスルファートナトリウム水和物 |
| Companies | 製造販売元／株式会社伏見製薬所, 発売元／伏見製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 緩下剤 |
| Therapeutic category codes | 872359 |
| YJ codes | 2359005F1277 |
| Approval numbers | 30100AMX00050000 |
| Package insert edition | 第1版 |
| Package insert date | Dec 1, 2023 |
| PMDA document key | 670137_2359005F1277_1 |
| PMDA company code | 670137 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: